APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Subcutaneous Immunoglobulins

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Selected research

Industry Growth & Trends

Global Subcutaneous Immunoglobulins Industry Growth and Trends Forecast to 2032

Report ID 174038210121 December 202576 pages

Choose your research edition.

Industry ResearchSubcutaneous Immunoglobulins Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Subcutaneous Immunoglobulins Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Subcutaneous Immunoglobulins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Subcutaneous Immunoglobulins Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Subcutaneous Immunoglobulins Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

Read the full market overview

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

Report Scope

This report provides a structured, data-driven view of the global Subcutaneous Immunoglobulins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Subcutaneous Immunoglobulins market size, estimates, and forecasts are presented in terms of sales volume (K Bottle) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Subcutaneous Immunoglobulins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Subcutaneous Immunoglobulins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Subcutaneous Immunoglobulins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Subcutaneous Immunoglobulins Market by Company

Shire (Baxalta)

Grifols

CSL

Subcutaneous Immunoglobulins Segment by Purity

0.1

0.2

Subcutaneous Immunoglobulins Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Subcutaneous Immunoglobulins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Immunoglobulins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Immunoglobulins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Immunoglobulins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Subcutaneous Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.1 Table 2. Major Company of 0.2 Table 3. Global Subcutaneous Immunoglobulins Sales by Purity (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 5. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2021-2026) Table 6. Global Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 7. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Purity (2021-2026) Table 8. Global Subcutaneous Immunoglobulins Price by Purity (2021-2026) & (USD/Bottle) Table 9. Global Subcutaneous Immunoglobulins Sales by Purity (2027-2032) & (K Bottle) Table 10. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2027-2032) Table 11. Global Subcutaneous Immunoglobulins Sales by Purity (2027-2032) & (US$ Million) Table 12. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Purity (2027-2032) Table 13. Global Subcutaneous Immunoglobulins Price by Purity (2027-2032) & (USD/Bottle) Table 14. North America Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 15. North America Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 16. Europe Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 17. Europe Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 18. Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 19. Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 20. Latin America Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 21. Latin America Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 22. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (K Bottle) Table 23. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2021-2026) & (US$ Million) Table 24. Subcutaneous Immunoglobulins Industry Trends Table 25. Subcutaneous Immunoglobulins Industry Drivers Table 26. Subcutaneous Immunoglobulins Industry Opportunities and Challenges Table 27. Subcutaneous Immunoglobulins Industry Restraints Table 28. Global Subcutaneous Immunoglobulins Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Subcutaneous Immunoglobulins Revenue Market Share by Company (2021-2026) Table 30. Global Subcutaneous Immunoglobulins Sales by Company (2021-2026) & (K Bottle) Table 31. Global Subcutaneous Immunoglobulins Sales Share by Company (2021-2026) Table 32. Global Subcutaneous Immunoglobulins Market Price by Company (2021-2026) & (USD/Bottle) Table 33. Global Subcutaneous Immunoglobulins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Subcutaneous Immunoglobulins Major Company Production Sites and Headquarters Table 35. Global Subcutaneous Immunoglobulins Company, Product Type & Application Table 36. Global Subcutaneous Immunoglobulins Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Subcutaneous Immunoglobulins Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Subcutaneous Immunoglobulins Sales by Region (2021-2026) & (K Bottle) Table 41. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2021-2026) Table 42. Global Subcutaneous Immunoglobulins Sales by Region (2021-2026) & (US$ Million) Table 43. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2021-2026) Table 44. Global Subcutaneous Immunoglobulins Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 45. Global Subcutaneous Immunoglobulins Sales by Region (2027-2032) & (K Bottle) Table 46. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Region (2027-2032) Table 47. Global Subcutaneous Immunoglobulins Sales by Region (2027-2032) & (US$ Million) Table 48. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Region (2027-2032) Table 49. Global Subcutaneous Immunoglobulins Sales (K Bottle), Value (US$ Million), Price (USD/Bottle) and Gross Margin (2027-2032) Table 50. Global Subcutaneous Immunoglobulins Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 52. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2021-2026) Table 53. Global Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 54. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2021-2026) Table 55. Global Subcutaneous Immunoglobulins Price by Application (2021-2026) & (USD/Bottle) Table 56. Global Subcutaneous Immunoglobulins Sales by Application (2027-2032) & (K Bottle) Table 57. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2027-2032) Table 58. Global Subcutaneous Immunoglobulins Sales by Application (2027-2032) & (US$ Million) Table 59. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2027-2032) Table 60. Global Subcutaneous Immunoglobulins Price by Application (2027-2032) & (USD/Bottle) Table 61. North America Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 62. North America Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 64. Europe Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 66. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 68. Latin America Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (K Bottle) Table 70. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2021-2026) & (US$ Million) Table 71. Shire (Baxalta) Company Information Table 72. Shire (Baxalta) Business Overview Table 73. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 74. Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio Table 75. Shire (Baxalta) Recent Development Table 76. Grifols Company Information Table 77. Grifols Business Overview Table 78. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 79. Grifols Subcutaneous Immunoglobulins Product Portfolio Table 80. Grifols Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 84. CSL Subcutaneous Immunoglobulins Product Portfolio Table 85. CSL Recent Development Table 86. North America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 87. North America Subcutaneous Immunoglobulins Sales by Country (2021-2026) & (K Bottle) Table 88. North America Subcutaneous Immunoglobulins Sales Market Share by Country (2021-2026) Table 89. North America Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032) & (K Bottle) Table 90. North America Subcutaneous Immunoglobulins Sales Market Share Forecast by Country (2027-2032) Table 91. North America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America Subcutaneous Immunoglobulins Market Size by Country (2021-2026) & (US$ Million) Table 93. North America Subcutaneous Immunoglobulins Market Share by Country (2021-2026) Table 94. North America Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America Subcutaneous Immunoglobulins Market Share Forecast by Country (2027-2032) Table 96. Europe Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 97. Europe Subcutaneous Immunoglobulins Sales by Country (2021-2026) & (K Bottle) Table 98. Europe Subcutaneous Immunoglobulins Sales Market Share by Country (2021-2026) Table 99. Europe Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032) & (K Bottle) Table 100. Europe Subcutaneous Immunoglobulins Sales Market Share Forecast by Country (2027-2032) Table 101. Europe Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe Subcutaneous Immunoglobulins Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe Subcutaneous Immunoglobulins Market Share by Country (2021-2026) Table 104. Europe Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe Subcutaneous Immunoglobulins Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Subcutaneous Immunoglobulins Sales by Country (2021-2026) & (K Bottle) Table 108. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032) & (K Bottle) Table 110. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Subcutaneous Immunoglobulins Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific Subcutaneous Immunoglobulins Market Share by Country (2021-2026) Table 114. Asia-Pacific Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific Subcutaneous Immunoglobulins Market Share Forecast by Country (2027-2032) Table 116. Latin America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 117. Latin America Subcutaneous Immunoglobulins Sales by Country (2021-2026) & (K Bottle) Table 118. Latin America Subcutaneous Immunoglobulins Sales Market Share by Country (2021-2026) Table 119. Latin America Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032) & (K Bottle) Table 120. Latin America Subcutaneous Immunoglobulins Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America Subcutaneous Immunoglobulins Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America Subcutaneous Immunoglobulins Market Share by Country (2021-2026) Table 124. Latin America Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America Subcutaneous Immunoglobulins Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (K Bottle): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2021-2026) & (K Bottle) Table 128. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032) & (K Bottle) Table 130. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa Subcutaneous Immunoglobulins Market Share by Country (2021-2026) Table 134. Middle East and Africa Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa Subcutaneous Immunoglobulins Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Subcutaneous Immunoglobulins Distributors List Table 139. Subcutaneous Immunoglobulins Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Subcutaneous Immunoglobulins Image Figure 2. Global Subcutaneous Immunoglobulins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Subcutaneous Immunoglobulins Market Size (2021-2032) & (US$ Million) Figure 4. Global Subcutaneous Immunoglobulins Sales (2021-2032) & (K Bottle) Figure 5. 0.1 Image Figure 6. Global 0.1 Sales YoY Growth (2021-2032) & (K Bottle) Figure 7. 0.2 Image Figure 8. Global 0.2 Sales YoY Growth (2021-2032) & (K Bottle) Figure 9. Global Subcutaneous Immunoglobulins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Subcutaneous Immunoglobulins Market Share by Type 2025 VS 2032 Figure 11. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Type in 2025 Figure 12. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Type in 2025 Figure 13. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Type in 2025 Figure 14. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Type in 2025 Figure 17. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Subcutaneous Immunoglobulins Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Primary Immunodeficiency Image Figure 24. Global Primary Immunodeficiency Sales YoY Growth (2021-2032) & (K Bottle) Figure 25. Secondary Immunodeficiency Image Figure 26. Global Secondary Immunodeficiency Sales YoY Growth (2021-2032) & (K Bottle) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Bottle) Figure 29. Global Subcutaneous Immunoglobulins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Subcutaneous Immunoglobulins Market Share by Application 2025 VS 2032 Figure 31. North America Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2025 Figure 32. North America Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2025 Figure 33. Europe Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2025 Figure 34. Europe Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2025 Figure 37. Latin America Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share in Value by Application in 2025 Figure 41. North America Subcutaneous Immunoglobulins Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 42. North America Subcutaneous Immunoglobulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Subcutaneous Immunoglobulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Subcutaneous Immunoglobulins Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 46. Europe Subcutaneous Immunoglobulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Subcutaneous Immunoglobulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Subcutaneous Immunoglobulins Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 50. Asia-Pacific Subcutaneous Immunoglobulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Subcutaneous Immunoglobulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Subcutaneous Immunoglobulins Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 54. Latin America Subcutaneous Immunoglobulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Subcutaneous Immunoglobulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country: 2021 VS 2025 VS 2032 (K Bottle) Figure 58. Middle East and Africa Subcutaneous Immunoglobulins Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Subcutaneous Immunoglobulins Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Subcutaneous Immunoglobulins Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Subcutaneous Immunoglobulins Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1
  • 0.2
Applications
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Companies covered
  • Shire (Baxalta)
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Subcutaneous Immunoglobulins Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Subcutaneous Immunoglobulins Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Subcutaneous Immunoglobulins Market by Purity
  6. 1.3.1 0.1
  7. 1.3.2 0.2
  8. 1.4 Global Subcutaneous Immunoglobulins Market Size by Purity
  9. 1.4.1 Global Subcutaneous Immunoglobulins Market Size Overview by Purity (2021-2032)
  10. 1.4.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Purity (2021-2026)
  11. 1.4.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Purity (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2021-2026)
  14. 1.5.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Purity (2021-2026)
  15. 1.5.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Purity (2021-2026)
  16. 1.5.4 South America Subcutaneous Immunoglobulins Sales Breakdown by Purity (2021-2026)
  17. 1.5.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Purity (2021-2026)
2 Global Market Dynamics
  1. 2.1 Subcutaneous Immunoglobulins Industry Trends
  2. 2.2 Subcutaneous Immunoglobulins Industry Drivers
  3. 2.3 Subcutaneous Immunoglobulins Industry Opportunities and Challenges
  4. 2.4 Subcutaneous Immunoglobulins Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Subcutaneous Immunoglobulins Revenue (2021-2026)
  2. 3.2 Global Top Players by Subcutaneous Immunoglobulins Sales (2021-2026)
  3. 3.3 Global Top Players by Subcutaneous Immunoglobulins Price (2021-2026)
  4. 3.4 Global Subcutaneous Immunoglobulins Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Subcutaneous Immunoglobulins Major Company Production Sites & Headquarters
  6. 3.6 Global Subcutaneous Immunoglobulins Company, Product Type & Application
  7. 3.7 Global Subcutaneous Immunoglobulins Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Subcutaneous Immunoglobulins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Subcutaneous Immunoglobulins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Subcutaneous Immunoglobulins Tier 1, Tier 2, and Tier 3
4 Subcutaneous Immunoglobulins Regional Status and Outlook
  1. 4.1 Global Subcutaneous Immunoglobulins Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Subcutaneous Immunoglobulins Historic Market Size by Region
  3. 4.2.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Region
  7. 4.3.1 Global Subcutaneous Immunoglobulins Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Subcutaneous Immunoglobulins Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Subcutaneous Immunoglobulins Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Subcutaneous Immunoglobulins by Application
  1. 5.1 Subcutaneous Immunoglobulins Market by Application
  2. 5.1.1 Primary Immunodeficiency
  3. 5.1.2 Secondary Immunodeficiency
  4. 5.1.3 Others
  5. 5.2 Global Subcutaneous Immunoglobulins Market Size by Application
  6. 5.2.1 Global Subcutaneous Immunoglobulins Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Subcutaneous Immunoglobulins Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Subcutaneous Immunoglobulins Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Subcutaneous Immunoglobulins Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Subcutaneous Immunoglobulins Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Subcutaneous Immunoglobulins Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Subcutaneous Immunoglobulins Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shire (Baxalta)
  2. 6.1.1 Shire (Baxalta) Company Information
  3. 6.1.2 Shire (Baxalta) Business Overview
  4. 6.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio
  6. 6.1.5 Shire (Baxalta) Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Subcutaneous Immunoglobulins Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Subcutaneous Immunoglobulins Product Portfolio
  18. 6.3.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Subcutaneous Immunoglobulins Sales by Country
  2. 7.1.1 North America Subcutaneous Immunoglobulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Subcutaneous Immunoglobulins Sales by Country (2021-2026)
  4. 7.1.3 North America Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032)
  5. 7.2 North America Subcutaneous Immunoglobulins Market Size by Country
  6. 7.2.1 North America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Subcutaneous Immunoglobulins Market Size by Country (2021-2026)
  8. 7.2.3 North America Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Subcutaneous Immunoglobulins Sales by Country
  2. 8.1.1 Europe Subcutaneous Immunoglobulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Subcutaneous Immunoglobulins Sales by Country (2021-2026)
  4. 8.1.3 Europe Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Subcutaneous Immunoglobulins Market Size by Country
  6. 8.2.1 Europe Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Subcutaneous Immunoglobulins Market Size by Country (2021-2026)
  8. 8.2.3 Europe Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Country
  2. 9.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Subcutaneous Immunoglobulins Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Subcutaneous Immunoglobulins Market Size by Country
  6. 9.2.1 Asia-Pacific Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Subcutaneous Immunoglobulins Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Subcutaneous Immunoglobulins Sales by Country
  2. 10.1.1 South America Subcutaneous Immunoglobulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Subcutaneous Immunoglobulins Sales by Country (2021-2026)
  4. 10.1.3 South America Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032)
  5. 10.2 South America Subcutaneous Immunoglobulins Market Size by Country
  6. 10.2.1 South America Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Subcutaneous Immunoglobulins Market Size by Country (2021-2026)
  8. 10.2.3 South America Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country
  2. 11.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Subcutaneous Immunoglobulins Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country
  6. 11.2.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Subcutaneous Immunoglobulins Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Subcutaneous Immunoglobulins Value Chain Analysis
  2. 12.1.1 Subcutaneous Immunoglobulins Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Subcutaneous Immunoglobulins Production Mode & Process
  7. 12.2 Subcutaneous Immunoglobulins Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Subcutaneous Immunoglobulins Distributors
  10. 12.2.3 Subcutaneous Immunoglobulins Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst